 |
Canadian Urological Association (CUA)Author: Canadian Urological Association / L'Association des urologues du Canada
The official podcast of the Canadian Urological Association (CUA). Le podcast officiel de l'association des urologues du Canada (AUC). Language: en Genres: Health & Fitness, Life Sciences, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens
Episode 61
Tuesday, 4 March, 2025
Episode NotesPodcast Host Disclosures:Dr. Black has received honoraria from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Biosyent, Bristol- Myers Squibb, EMD-Serono, Ferring, Janssen Oncology, Merck, Nanology, Nonagen, Pfizer, Prokarium, Protara, QED, Roche Canada, Sanofi Canada, STIMIT, Urogen Pharma and VerityDr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clinical trials directed to institutions from BMS (Inst), BioCanRx (Inst), Novartis (Inst), Roche (Inst), Ipsen (Inst), EMD Serrono (Inst).Accreditation:This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. After completing the self-assessment questions at the link below, listeners are eligible to claim Section 3 self-assessment credits. Obtain Section 3 Credits Here >
